Xiaoling Chi
Impact in
- Hepatology top 5%
- Hepatitis C virus research
- Liver Diseases and Immunity
- Liver Disease and Transplantation
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver physiology and pathology
-
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies
Papers in
- Epidemiology 21
- Liver Disease Diagnosis and Treatment 17
- Hepatitis B Virus Studies 10
-
- Hepatitis C virus research 3
- Liver Diseases and Immunity 2
- Liver Disease and Transplantation 1
- Hepatocellular Carcinoma Treatment and Prognosis 1
- Co-authors
- Huanming Xiao (21 shared papers)Xueen Liu (3 shared papers)Hui Sheng Zhuang (3 shared papers)Ming Valerie Lin (7 shared papers)Yi Luo (1 shared paper)Shaoling Li (1 shared paper)Qi Wang (1 shared paper)Ming Hong (1 shared paper)
- Journals
- Frontiers in Pharmacology (2 papers)International Immunopharmacology (2 papers)Evidence-based Complementary and Alternative Medicine (2 papers)Scientific Reports (1 paper)Bioscience Reports (1 paper)
- Partner nations
- ChinaItalyUnited Kingdom
In The Last Decade
Xiaoling Chi
29 papers receiving 331 citations
Peers
Comparison fields: 5 of 62
- Hepatology 107
- Epidemiology 194
- Pharmacology 15
- Cell Biology 18
- Cancer Research 14
Countries citing papers authored by Xiaoling Chi
This map shows the geographic impact of Xiaoling Chi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoling Chi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoling Chi more than expected).
Fields of papers citing papers by Xiaoling Chi
This network shows the impact of papers produced by Xiaoling Chi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoling Chi. The network helps show where Xiaoling Chi may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoling Chi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 65 | |
| 2 | 2021 | 45 | |
| 3 | 2020 | 33 | |
| 4 | 2021 | 20 | |
| 5 | 2018 | 17 | |
| 6 | 2020 | 16 | |
| 7 | 2020 | 15 | |
| 8 | 2021 | 12 | |
| 9 | 2022 | 12 | |
| 10 | 2023 | 11 | |
| 11 | 2024 | 11 | |
| 12 | 2019 | 9 | |
| 13 | 2021 | 9 | |
| 14 | 2022 | 8 | |
| 15 | 2021 | 8 | |
| 16 | 2024 | 6 | |
| 17 | 2016 | 5 | |
| 18 | 2024 | 5 | |
| 19 | 2016 | 4 | |
| 20 | 2018 | 4 |
About Xiaoling Chi
Xiaoling Chi is a scholar working on Epidemiology, Hepatology, Obstetrics and Gynecology, Complementary and alternative medicine and Reproductive Medicine, having authored 31 papers that have together received 332 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (17 papers), Hepatitis B Virus Studies (10 papers), Hepatitis C virus research (3 papers), Liver Diseases and Immunity (2 papers), Animal Virus Infections Studies (1 paper), Liver Disease and Transplantation (1 paper), Hepatocellular Carcinoma Treatment and Prognosis (1 paper) and Pharmacological Effects of Natural Compounds (1 paper). The work is most often cited by research in Hepatology (107 citations), Epidemiology (194 citations), Pharmacology (15 citations), Cell Biology (18 citations) and Cancer Research (14 citations). Xiaoling Chi has collaborated with scholars based in China, Italy and United Kingdom. Frequent co-authors include Huanming Xiao, Xueen Liu, Hui Sheng Zhuang, Ming Valerie Lin, Yi Luo, Shaoling Li, Qi Wang, Ming Hong, Cong Yang and Lei Song. Their work appears in journals such as Frontiers in Pharmacology, International Immunopharmacology, Evidence-based Complementary and Alternative Medicine, Scientific Reports and Bioscience Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.